Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-04-25 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学科技股份有限公司2023年度独立董事述职报告-戚啸艳（离任）
Regulatory Filings
2024-04-25 Chinese
公证天业会计师事务所（特殊普通合伙）关于南微医学科技股份有限公司2023年内部控制审计报告
Regulatory Filings
2024-04-25 Chinese
南微医学科技股份有限公司2023年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2023年度募集资金存放与使用情况的专项报告" which translates to "2023 Annual Special Report on the Deposit and Use of Raised Funds." It details the amount of funds raised, their usage, management, and compliance with regulatory requirements. It includes detailed financial figures about fundraising, usage, balances, and investment projects. The document also contains auditor and sponsor institution opinions on the fundraising usage report. This is a specialized report focused on the management and use of capital raised by the company, not a general annual report or earnings release. It is not a simple announcement or certification but a substantive report on fundraising usage. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2024-04-25 Chinese
南微医学科技股份有限公司2023年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2023 Annual Report Summary" of 南微医学科技股份有限公司, indicating it is a summary of the full annual report. It contains detailed financial data for the year 2023, including total assets, net profit, revenue, and quarterly breakdowns. It also includes extensive business descriptions, industry analysis, risk factors, and dividend distribution plans. The length of the document (over 11,000 characters) and the presence of substantive financial data and management discussion confirm it is a full annual report rather than a brief announcement or a certification. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2024-04-25 Chinese
南微医学科技股份有限公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of 南微医学科技股份有限公司 (Micro-Tech (Nanjing) Co., Ltd.). It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, voting procedures, and other governance-related rules. There is no indication of financial data, audit results, earnings, or any announcement of voting results. The content is a governance document outlining the internal rules and regulations of the company. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not a brief announcement or summary.
2024-04-25 Chinese
南微医学科技股份有限公司关于公证天业会计师事务所（特殊普通合伙）履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as a report on the accounting firm's performance in fulfilling its supervisory duties for the 2023 fiscal year audit of the company. It details the auditor's qualifications, audit process, quality control, and evaluation of the auditor's work. It does not contain the actual financial statements or audit opinions themselves but rather an assessment and description of the auditor's role and performance. The document length is under 5,000 characters and reads like a standalone audit-related report rather than a full annual report or audit report. This fits the category of an Audit Report / Information (AR), which includes standalone audit reports and information about audit processes and results, excluding full annual reports. Therefore, the classification is AR with high confidence. FY 2023
2024-04-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.